1. Probing the influence of citrate-capped gold nanoparticles on an amyloidogenic protein.
- Author
-
Brancolini G, Corazza A, Vuano M, Fogolari F, Mimmi MC, Bellotti V, Stoppini M, Corni S, and Esposito G
- Subjects
- Amino Acid Sequence, Amyloidogenic Proteins metabolism, Gold metabolism, Molecular Docking Simulation, Molecular Dynamics Simulation, Particle Size, Protein Multimerization drug effects, Protein Structure, Secondary, Static Electricity, Amyloidogenic Proteins chemistry, Citric Acid chemistry, Gold chemistry, Gold pharmacology, Metal Nanoparticles chemistry
- Abstract
Nanoparticles (NPs) are known to exhibit distinct physical and chemical properties compared with the same materials in bulk form. NPs have been repeatedly reported to interact with proteins, and this interaction can be exploited to affect processes undergone by proteins, such as fibrillogenesis. Fibrillation is common to many proteins, and in living organisms, it causes tissue-specific or systemic amyloid diseases. The nature of NPs and their surface chemistry is crucial in assessing their affinity for proteins and their effects on them. Here we present the first detailed structural characterization and molecular mechanics model of the interaction between a fibrillogenic protein, β2-microglobulin, and a NP, 5 nm hydrophilic citrate-capped gold nanoparticles. NMR measurements and simulations at multiple levels (enhanced sampling molecular dynamics, Brownian dynamics, and Poisson-Boltzmann electrostatics) explain the origin of the observed protein perturbations mostly localized at the amino-terminal region. Experiments show that the protein-NP interaction is weak in the physiological-like, conditions and do not induce protein fibrillation. Simulations reproduce these findings and reveal instead the role of the citrate in destabilizing the lower pH protonated form of β2-microglobulin. The results offer possible strategies for controlling the desired effect of NPs on the conformational changes of the proteins, which have significant roles in the fibrillation process.
- Published
- 2015
- Full Text
- View/download PDF